Barclays
BHVN icon

Barclays’s Biohaven BHVN Stock Holding History

Barclays’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$1.13K – 5059
2025
Q4 		$1.13K Sell
100
-420,800
-100% -$5.21M ﹤0.01% 5080
2025
Q3 		$6.32M Buy
+420,900
New +$6.13M ﹤0.01% 2016
2024
Q1 		– Sell
-90,000
Closed -$3.85M – 5083
2023
Q4 		$3.85M Buy
+90,000
New +$2.8M ﹤0.01% 2351

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's BHVN Position: Q1 2026 in Review

Barclays reduced its Biohaven (BHVN) stake by 61% in Q1 2026, selling an estimated $2.13M and leaving 125,822 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2720.

Barclays first reported a position in BHVN in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.7M in Q4 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Barclays held 125,822 shares of Biohaven worth $1.06M as of Q1 2026.
  • Barclays sold 195,024 Biohaven shares in Q1 2026, an estimated $2.13M.
  • Biohaven made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2720 holding.
  • Barclays first reported a position in Biohaven in Q4 2022 and has held it in 14 quarters since.
  • Barclays's Biohaven position peaked at $14.7M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.